Nanoparticle technology in bone tissue engineering

Journal of Drug Targeting

Volumn 15, Issue 4, 2007, Pages 241-252

  Kim, Kyobum ^a   Fisher, John P ^a  

^a UNIVERSITY OF MARYLAND   (United States)

Author keywords

Bone tissue engineering; Composite scaffold; Gene delivery; Growth factor; Nanoparticle

Indexed keywords

ADENOVIRUS VECTOR; ALKALINE PHOSPHATASE BONE ISOENZYME; BONE MORPHOGENETIC PROTEIN 2; CALCIUM; CALCIUM PHOSPHATE; CHITOSAN; COLLAGEN TYPE 1; DENDRIMER; HYDROXYAPATITE; INDOMETACIN; LIPOSOME; MACROGOL; MESSENGER RNA; MOLECULAR SCAFFOLD; NANOCOMPOSITE; NANOPARTICLE; POLY(METHYL METHACRYLATE); POLYAMIDOAMINE; POLYBUTYLENE TEREPHTHALATE; POLYCAPROLACTONE; POLYGLACTIN; POLYLACTIC ACID; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; SIALOPROTEIN; SILICON DIOXIDE; SINGLE WALLED NANOTUBE; TITANIUM DIOXIDE; TRANSCRIPTION FACTOR RUNX2; UNINDEXED DRUG; VASCULOTROPIN; BIOMATERIAL;

ARTICLE; BIOCOMPATIBILITY; BIODEGRADABILITY; BONE DEFECT; BONE DEVELOPMENT; BONE GRAFT; BONE GROWTH; BONE MINERALIZATION; BONE REGENERATION; BONE STRENGTH; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CERAMIC PROSTHESIS; COLLAGEN SYNTHESIS; COMPOSITE MATERIAL; DRUG EFFICACY; DRUG MECHANISM; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; GENE TARGETING; GENE TRANSFER; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; HUMAN; MESENCHYMAL STEM CELL; MICELLE; NANOTECHNOLOGY; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKULL DEFECT; TISSUE ENGINEERING; VIRAL GENE DELIVERY SYSTEM; WEIGHT BEARING; METHODOLOGY; REVIEW;

BIOCOMPATIBLE MATERIALS; BONE REGENERATION; NANOPARTICLES; NANOTECHNOLOGY; TISSUE ENGINEERING;

EID: 34447536832     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.1080/10611860701289818     Document Type: Article

References (72)

1. Babensee, JE, Mclntire, LV and Mikos, AG (2000) Growth factor delivery for tissue engineering. Pharm Res, 17:5, pp. 497-504.
2. Bhattarai, N., Edmondson, D., Veiseh, O., Matsen, FA and Zhang, M. (2005) Electrospun chitosan-based nanofibers and their cellular compatibility. Biomaterials, 26:31, pp. 6176-6184.
3. Bhattarai, SR, Bhattarai, N., Yi, HK, Hwang, PM, Cha, DI and Kim, HY (2004) Novel biodegradable electrospun membrane: Scaffold for tissue engineering. Biomaterials, 25:13, pp. 2595-2602.
4. Chen, J., Chu, B. and Hsiao, BS (2006) Mineralization of hydroxyapatite in electrospun nanofibrous poly(-lactic acid) scaffolds. J Biomed Mater Res A, 79:2, pp. 307-317.
5. Chen, VJ, Smith, LA and Ma, PX (2006) Bone regeneration on computer-designed nanofibrous scaffolds. Biomaterials, 27:21, pp. 3973-3979.
6. Choi, SW, Kim, WS and Kim, JH (2005) Surface-functionalized nanoparticles for controlled drug delivery. Methods Mol Biol, 303, pp. 121-131.
7. Choi, JS, Ko, KS, Park, JS, Kim, YH, Kim, SW and Lee, M. (2006) Dexamethasone conjugated poly(amidoamine) dendrimer as a gene carrier for efficient nuclear translocation. Int J Pharm, 320:12, pp. 171-178.
8. Cohen, H., Levy, RJ, Gao, J., Fishbein, I., Kousaev, V., Sosnowski, S., Slomkowski, S. and Golomb, G. (2000) Sustained delivery and expression of DNA encapsulated in polymeric nanoparticles. Gene Ther, 7:22, pp. 1896-1905.
9. Corsi, K., Chellat, F., Yahia, L. and Fernandes, JC (2003) Mesenchymal stem cells, MG63 and HEK293 transfection using chitosan-DNA nanoparticles. Biomaterials, 24:7, pp. 1255-1264.
10. Dang, JM and Leong, KW (2006) Natural polymers for gene delivery and tissue engineering. Adv Drug Deliv Rev, 58:4, pp. 487-499.
11. Duncan, R. (2006) Polymer conjugates as anticancer nanomedicines. Nat Rev Cancer, 6:9, pp. 1-14.
12. Emerich, DF and Thanos, CG (2005) Nanomedicine. Curr Nanosci, 1, pp. 177-188.
13. Erbacher, P., Zou, S., Bettinger, T., Steffan, AM and Remy, JS (1998) Chitosan-based vector/DNA complexes for gene delivery: Biophysical characteristics and transfection ability. Pharm Res, 15:9, pp. 1332-1339.
14. Goto, K., Tamura, J., Shinzato, S., Fujibayashi, S., Hashimoto, M., Kawashita, M., Kokubo, T. and Nakamura, T. (2005) Bioactive bone cements containing nano-sized titania particles for use as bone substitutes. Biomaterials, 26:33, pp. 6496-6505.
15. Horch, RA, Shahid, N., Mistrry, AS, Timmer, MD, Mikos, AG and Rarron, AR (2004) Nanoreinforcement of poly(propylene fumarate)-based networks with surface modified alumoxane nanoparticles for bone tissue engineering. Biomacromolecules, 5, pp. 1990-1998.
16. Hosseinkhani, H. and Tabata, Y. (2006) Self assembly of DNA nanoparticles with polycations for the delivery of genetic materials into cells. J Nanosci Nanotechnol, 6:8, pp. 2320-2328.
17. Jang, JS, Kim, SY, Lee, SB, Kim, KO, Han, JS and Lee, YM (2006) Poly(ethylene glycol)/poly(ε-caprolactone) diblock copolymeric nanoparticles for non-viral gene delivery: The role of charge group and molecular weight in particle formation, cytotoxicity and transfection. J Control Release, 113:2, pp. 173-182.
18. Kanayama, N., Fukushima, S., Nishiyama, N., Itaka, K., Jang, WD, Miyata, K., Yamasaki, Y., Chung, UI and Kataoka, K. (2006) A PEG-based biocompatible block catiomer with high 17 buffering capacity for the construction of polyplex micelles showing efficient gene transfer toward primary cells. ChemMedChem, 1:4, pp. 439-444.
19. Kay, S., Thapa, A., Haberstroh, KM and Webster, TJ (2002) Nanostructured polymer/nanophase ceramic composites enhance osteoblast and chondrocyte adhesion. Tissue Eng, 8:5, pp. 753-761.
20. Kim, SS, Sun, PM, Jeon, O., Choi, C Yong and Kim, BS (2006) Poly(lactide-co-glycolide)/hydroxyapatite composite scaffolds for bone tissue engineering. Biomaterials, 27:8, pp. 1399-1409.
21. Kim, SS, Ahn, KM, Park, MS, Lee, JH, Choi, CY and Kim, BS (2007) A poly(lactide-co-glycolide)/hydroxyapatite composite scaffold with enhanced osteoconductivity. J Biomed Mater Res A, 80:1, pp. 206-215.
22. Kirker-Head, CA (2000) Potential applications and delivery strategies for bone morphogenetic proteins. Adv Drug Deliv Rev, 43:1, pp. 65-92.
23. Kofron, MD and Laurencin, CT (2006) Bone tissue engineering by gene delivery. Adv Drug Deliv Rev, 58:4, pp. 555-576.
24. Kushibiki, T. and Tabata, Y. (2005) Preparation of poly(ethylene glycol)-introduced cationized gelatin as a non-viral gene carrier. J Biomater Sci Polym Ed, 16:11, pp. 1447-1461.
25. Li, RH and Wozney, JM (2001) Delivering on the promise of bone morphogenetic proteins. Trends Biotechnol, 19:7, pp. 255-265.
26. Liu, Q., de Wijn, JR and van Blitterswijk, CA (1998) Composite biomaterials with chemical bonding between hydroxyapatite filler particles and PEG/PBT copolymer matrix. J Biomed Mater Res A, 40:3, pp. 490-497.
27. Liu, H., Slamovich, EB and Webster, TJ (2005) Increased osteoblast functions on nanophase titania dispersed in poly-lactic-co-glycolicacid composites. Nanotechnology, 16:7, pp. S601-S608.
28. Pei, Y., Zhang, X., Zhou, Z., Yuan, W., Zhou, J., Zhu, J. and Gao, X. (2001) PEGylated PLGA nanoparticles as protein carriers: Synthesis, preparation and biodistribution in rats. J Control Release, 71:2, pp. 203-211.
29. Li, WJ, Laurencin, CT, Caterson, EJ, Tuan, RS and Ko, FK (2002) Electrospun nanofibrous structure: A novel scaffold for tissue engineering. J Biomed Mater Res, 60:4, pp. 613-621.
30. Li, WJ, Tuli, R., Huang, X., Laquerriere, P. and Tuan, RS (2005) Multilineage differentiation of human mesenchymal stem cells in a three-dimensional nanofibrous scaffold. Biomaterials, 26:25, pp. 5158-5166.
31. Li, WJ, Tuli, R., Okafor, C., Derfoul, A., Danielson, KG, Hall, DJ and Tuan, RS (2005) A three-dimensional nanofibrous scaffold for cartilage tissue engineering using human mesenchymal stem cells. Biomaterials, 26:6, pp. 599-609.
32. Liu, H., Slamovich, EB and Webster, TJ (2006) Increased osteoblast functions among nanophase titania/poly(lactide-co-glycolide) composites of the highest nanometer surface roughness. J Biomed Mater Res A, 78:4, pp. 798-807.
33. Yaszemski, MJ and Mikos, AG (2001) TGF-beta1 release from biodegradable polymer microparticles: Its effects on marrow stromal osteoblast function. J Bone Joint Surg Am, 83, pp. S82-S91.
34. Mansouri, S., Lavigne, P., Corsi, K., Benderdour, M., Beaumont, E. and Fernandes, JC (2004) Chitosan-DNA nanoparticles as non-viral vectors in gene therapy: Strategies to improve transfection efficacy. Eur J Pharm Biopharm, 57:1, pp. 1-8.
35. Mansouri, S., Cuie, Y., Winnik, F., Shi, Q., Lavigne, P., Benderdour, M., Beaumont, E. and Fernandes, JC (2006) Characterization of folate-chitosan-DNA nanoparticles for gene therapy. Biomaterials, 27:9, pp. 2060-2065.
36. Matsuo, T., Sugita, T., Kubo, T., Yasunaga, Y., Ochi, M. and Murakami, T. (2003) Injectable magnetic liposomes as a novel carrier of recombinant human BMP-2 for bone formation in a rat bone-defect model. J Biomed Mater Res A, 66:4, pp. 747-754.
37. McAllister, K., Sazani, P., Adam, M., Cho, MJ, Rubinstein, M., Samulski, RJ and DeSimone, JM (2002) Polymeric nanogels produced via inverse microemulsion polymerization as potential gene and antisense delivery agents. J Am Chem Soc, 124:51, pp. 15198-15207.
38. Meinel, L., llli, OE, Zapf, J., Malfanti, M., Merkle, H Peter and Gander, B. (2001) Stabilizing insulin-like growth factor-l in poly(D,L,-lactide-co-glycolide) microsphere. J Control Release, 70:1, pp. 193-202.
39. Moghimi, SM, Hunter, AC and Murray, JC (2005) Nanomedicine: Current status and future prospects. FASEB J, 19:3, pp. 311-330.
40. Nishiyama, N. and Kataoka, K. (2006) Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery. Pharmacol Ther, 112:3, pp. 630-648.
41. Nishiyama, N. and Kataoka, K. (2006) Nanostructured devices based on block copolymer assemblies for drug delivery: Designing structures for enhanced drug formation. Adv Polym Sci, 193, pp. 67-101.
42. Ohashi, S., Kubo, T., Ikeda, T., Arai, Y., Takahashi, K., Hirasawa, Y., Takigawa, M., Satoh, E., Imanishi, J. and Mazda, O. (2001) Cationic polymer-mediated genetic transduction into cultured human chondrosarcoma-derived HCS-2/8 cells. J Orthop Sci, 6:1, pp. 75-81.
43. Oldham, JB, Zhu, X., Porter, BD, Hefferan, TE, Larson, DR, Currier, BL, Mikos, AG and Yaszemski, MJ (2000) Biological activity of rhBMP-2 released from PLGA microspheres. J Biomech Eng, 122:3, pp. 289-292.
44. Ono, I., Yamashita, T., Jin, HY, Ito, Y., Hamada, H., Akasaka, Y., Nakasu, M., Ogawa, T. and Jimbow, K. (2004) Combination of porous hydroxyapatite and cationic liposomes as a vector for BMP-2 gene therapy. Biomaterials, 25:19, pp. 4709-4718.
45. Orban, JM, Marra, KG and Hollinger, JO (2002) Composition options for tissue-engineered bone. Tissue Eng, 8, pp. 529-539.
46. Panyam, J. and Labhasetwar, V. (2003) Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev, 55, pp. 329-347.
47. Park, J., Ries, J., Gelse, K., Kloss, F., von der Mark, K., Wiltfang, J., Neukam, FW and Schneider, H. (2003) Bone regeneration in critical size defects by cell-mediated BMP-2 gene transfer: A comparison of adenoviral vectors and liposomes. Gene Ther, 10:13, pp. 1089-1098.
48. Prabha, S., Zhou, WZ, Panyam, J. and Labhasetwar, V. (2002) Size-dependency of nanoparticle-mediated gene transfection: Studies with fractionated nanoparticles. Int J Pharm, 244:12, pp. 105-115.
49. Putnam, D. (2006) Polymers for gene delivery across length scales. Nat Mater, 5:6, pp. 439-451.
50. Rose, FR and Oreffo, RO (2002) Breakthroughs and views, bone tissue engineering: Hope vs. hype. Biochem Biophys Res Commun, 292, pp. 1-7.
51. Rose, FR, Hou, Q. and Oreffo, RO (2004) Delivery systems for bone growth factors-the new players in skeletal regeneration. J Pharm Pharmacol, 56:4, pp. 415-427.
52. Salgado, AJ, Coutinho, OP and Reis, RL (2004) Bone tissue engineering: State of the art and future trends. Macromol Biosci, 4, pp. 743-765.
53. Sato, M. and Webster, TJ (2004) Nanobiotechnology: Implications for the future of nanotechnology in orthopedic applications. Expert Rev Med Dev, 1:1, pp. 105-114.
54. Shen, H., Tan, J. and Saltzman, WM (2004) Surface-mediated gene transfer from nanocomposites of controlled texture. Nat Mater, 3:8, pp. 569-574.
55. Shin, M., Yoshimoto, H. and Vacanti, JP (2004) In vivo bone tissue engineering using mesenchymal stem cells on a novel electrospun nanofibrous scaffold. Tissue Eng, 10:12, pp. 33-41.
56. Shi, X., Hudson, JL, Spicer, PP, Tour, JM, Krishnamoorti, R. and Mikos, AG (2006) Injectable nanocomposites of single-walled carbon nanotubes and biodegradable polymers for bone tissue engineering. Biomacromolecules, 7:7, pp. 2237-2242.
57. Smith, LA and Ma, PX (2004) Nano-fibrous scaffolds for tissue engineering. Colloids Surf B Biointerfaces, 39:3, pp. 125-131.
58. Southwood, LL, Frisbie, DD, Kawcak, CE and Mcilwraith, CW (2004) Delivery of growth factors using gene therapy to enhance bone healing. Vet Surg, 33, pp. 565-578.
59. Svenson, S. and Tomalia, DA (2005) Dendrimers in biomedical applications - reflections on the field. Adv Drug Deliv Rev, 57:15, pp. 2106-2129.
60. Tabata, Y. (2005) Nanomaterials of drug delivery systems for tissue regeneration. Methods Mol Biol, 300, pp. 81-100.
61. Tuzlakoglu, K., Bolgen, N., Salgado, AJ, Gomes, ME, Piskin, E. and Reis, RL (2005) Nano- and micro-fiber combined scaffolds: A new architecture for bone tissue engineering. J Mater Sci Mater Med, 16:12, pp. 1099-1104.
62. Webster, TJ and Smith, TA (2005) Increased osteoblast function on PLGA composites containing nanophase titania. J Biomed Mater Res A, 74:4, pp. 677-686.
63. Webster, TJ, Siegel, RW and Bizios, R. (1999) Osteoblast adhesion on nanophase ceramics. Biomaterials, 10:13, pp. 1221-1227.
64. Wei, G. and Ma, PX (2004) Structure and properties of nano-hydroxyapatite/polymer composite scaffolds for bone tissue engineering. Biomaterials, 25:19, pp. 4749-4757.
65. Woo, KM, Chen, VJ and Ma, PX (2003) Nano-fibrous scaffolding architecture selectively enhances protein adsorption contributing to cell attachment. J Biomed Mater Res A, 67:2, pp. 531-537.
66. Woo, KM, Jun, JH, Chen, VJ, Seo, J., Baek, JH, Ryoo, HM, Kim, GS, Somerman, MJ and Ma, PX (2007) Nano-fibrous scaffolding promotes osteoblast differentiation and biomineralization. Biomaterials, 28:2, pp. 335-343.
67. Xu, HH (1999) Dental composite resins containing silica-fused ceramic single-crystalline whiskers with various filler levels. J Dent Res, 78, pp. 1304-1311.
68. Xu, HH, Smith, DT and Simon, CG (2004) Strong and bioactive composites containing nano-silica-fused whiskers for bone repair. Biomaterials, 25:19, pp. 4615-4626.
69. Yamamoto, M. and Tabata, Y. (2006) Tissue engineering by modulated gene delivery. Adv Drug Deliv Rev, 58:4, pp. 535-554.
70. Jia, GL (2006) Formulation and characterization of poly (D,L,-lactide-co-glycolide) nanoparticle containing vascular endothelial growth factor for gene delivery. J Clin Pharm Ther, 31:1, pp. 43-48.
71. Yoo, JJ and Rhee, SH (2004) Evaluations of bioactivity and mechanical properties of poly (e-caprolactone)/silica nanocomposite following heat treatment. J Biomed Mater Res A, 68:3, pp. 401-410.
72. Yoshimoto, H., Shin, YM, Terai, H. and Vacanti, JP (2003) A biodegradable nanofiber scaffold by electrospinning and its potential for bone tissue engineering. Biomaterials, 24:12, pp. 2077-2082.